Response of High-Risk MDS to Azacitidine and Lenalidomide is Impacted by Baseline and Acquired Mutations in a Cluster of Three Inositide-Specific Genes
Author
McCubrey, James A.
Date
2019-09
Citation:
APA:
McCubrey, James A.. (September 2019).
Response of High-Risk MDS to Azacitidine and Lenalidomide is Impacted by Baseline and Acquired Mutations in a Cluster of Three Inositide-Specific Genes.
,
(),
-
. Retrieved from
http://hdl.handle.net/10342/9631
MLA:
McCubrey, James A..
"Response of High-Risk MDS to Azacitidine and Lenalidomide is Impacted by Baseline and Acquired Mutations in a Cluster of Three Inositide-Specific Genes". .
. (),
September 2019.
May 07, 2024.
http://hdl.handle.net/10342/9631.
Chicago:
McCubrey, James A.,
"Response of High-Risk MDS to Azacitidine and Lenalidomide is Impacted by Baseline and Acquired Mutations in a Cluster of Three Inositide-Specific Genes," , no.
(September 2019),
http://hdl.handle.net/10342/9631 (accessed
May 07, 2024).
AMA:
McCubrey, James A..
Response of High-Risk MDS to Azacitidine and Lenalidomide is Impacted by Baseline and Acquired Mutations in a Cluster of Three Inositide-Specific Genes. .
September 2019;
():
.
http://hdl.handle.net/10342/9631. Accessed
May 07, 2024.
Collections